{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:12:32Z","timestamp":1779149552032,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":48,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"crossref","award":["ETK2023013"],"award-info":[{"award-number":["ETK2023013"]}],"id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46524-8","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:36:25Z","timestamp":1775043385000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic analysis reveals the role of gut microbiota metabolic disorders in heart failure due to congenital heart disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Qi-Liang","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong-Xia","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ting","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeng-Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"6","key":"46524_CR1","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"CW Yancy","year":"2017","unstructured":"Yancy, C. W. et al. 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart failure Society of America. J. Am. Coll. Cardiol. 70(6), 776\u2013803 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"46524_CR2","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/ejhf.1629","volume":"21","author":"M Metra","year":"2019","unstructured":"Metra, M. & Lucioli, P. Corrigendum to \u201cPrevalence of heart failure and left ventricular dysfunction in China: The China Hypertension Survey, 2012\u20132015\u201d. Eur. J. Heart Fail. 21, 1329\u20131337 (2019).","journal-title":"Eur. J. Heart Fail."},{"issue":"7181","key":"46524_CR3","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/nature06798","volume":"451","author":"JO Mudd","year":"2008","unstructured":"Mudd, J. O. & Kass, D. A. Tackling heart failure in the twenty-first century. Nature 451(7181), 919\u2013928 (2008).","journal-title":"Nature"},{"issue":"10","key":"46524_CR4","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/ejhf.890","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel, O. et al. Clinical phenotypes and outcome of patients hospitalized for acute heart failure: The ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 19(10), 1242\u20131254 (2017).","journal-title":"Eur J Heart Fail."},{"issue":"16","key":"46524_CR5","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","volume":"73","author":"WHW Tang","year":"2019","unstructured":"Tang, W. H. W., B\u00e4ckhed, F., Landmesser, U. & Hazen, S. L. Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. J. Am. Coll. Cardiol. 73(16), 2089\u20132105 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"7","key":"46524_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/CIRCRESAHA.117.309715","volume":"120","author":"WH Tang","year":"2017","unstructured":"Tang, W. H., Kitai, T. & Hazen, S. L. Gut microbiota in cardiovascular health and disease. Circ Res. 120(7), 1183\u20131196 (2017).","journal-title":"Circ Res."},{"issue":"12","key":"46524_CR7","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","volume":"21","author":"Y Nagatomo","year":"2015","unstructured":"Nagatomo, Y. & Tang, W. H. Intersections between microbiome and heart failure: Revisiting the gut hypothesis. J. Card. Fail. 21(12), 973\u2013980 (2015).","journal-title":"J. Card. Fail."},{"issue":"15","key":"46524_CR8","doi-asserted-by":"publisher","first-page":"1321395","DOI":"10.3389\/fimmu.2024.1321395","volume":"26","author":"A Luqman","year":"2024","unstructured":"Luqman, A. et al. Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder. Front. Immunol. 26(15), 1321395 (2024).","journal-title":"Front. Immunol."},{"issue":"4","key":"46524_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s11154-019-09519-7","volume":"20","author":"M Branchereau","year":"2019","unstructured":"Branchereau, M., Burcelin, R. & Heymes, C. The gut microbiome and heart failure: A better gut for a better heart. Rev. Endocr. Metab. Disord. 20(4), 407\u2013414 (2019).","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"8","key":"46524_CR10","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.3390\/cells12081158","volume":"12","author":"VV Lupu","year":"2023","unstructured":"Lupu, V. V. et al. The implication of the gut microbiome in heart failure. Cells 12(8), 1158 (2023).","journal-title":"Cells"},{"issue":"3","key":"46524_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jchf.2015.10.009","volume":"4","author":"E Pasini","year":"2016","unstructured":"Pasini, E. et al. Pathogenic gut flora in patients with chronic heart failure. JACC Heart Fail. 4(3), 220\u2013227 (2016).","journal-title":"JACC Heart Fail."},{"issue":"3","key":"46524_CR12","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1002\/ehf2.12155","volume":"4","author":"M Luedde","year":"2017","unstructured":"Luedde, M. et al. Heart failure is associated with depletion of core intestinal microbiota. ESC Heart Fail. 4(3), 282\u2013290 (2017).","journal-title":"ESC Heart Fail."},{"issue":"1","key":"46524_CR13","doi-asserted-by":"publisher","first-page":"102179","DOI":"10.1016\/j.cpcardiol.2023.102179","volume":"49","author":"H Jain","year":"2024","unstructured":"Jain, H. et al. Unveiling the relationship between gut microbiota and heart failure: Recent understandings and insights. Curr. Probl. Cardiol. 49(1), 102179 (2024).","journal-title":"Curr. Probl. Cardiol."},{"issue":"7","key":"46524_CR14","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/ejhf.1409","volume":"21","author":"O Chioncel","year":"2019","unstructured":"Chioncel, O. & Ambrosy, A. P. Trimethylamine N-oxide and risk of heart failure progression: Marker or mediator of disease. Eur. J. Heart Fail. 21(7), 887\u2013890 (2019).","journal-title":"Eur. J. Heart Fail."},{"issue":"18","key":"46524_CR15","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.3390\/nu14183758","volume":"14","author":"P Zhao","year":"2022","unstructured":"Zhao, P., Zhao, S., Tian, J. & Liu, X. Significance of gut microbiota and short-chain fatty acids in heart failure. Nutrients 14(18), 3758 (2022).","journal-title":"Nutrients"},{"issue":"16","key":"46524_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2147\/IDR.S390582","volume":"5","author":"X Guan","year":"2023","unstructured":"Guan, X. & Sun, Z. The role of intestinal flora and its metabolites in heart failure. Infect Drug Resist. 5(16), 51\u201364 (2023).","journal-title":"Infect Drug Resist."},{"issue":"45","key":"46524_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035795","volume":"102","author":"M Shi","year":"2023","unstructured":"Shi, M., Wei, J., Yuan, H., Li, Y. & Guo, Z. The role of the gut microbiota and bile acids in heart failure: A review. Medicine (Baltimore) 102(45), e35795 (2023).","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"46524_CR18","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.3390\/jpm12111805","volume":"12","author":"M Yukino-Iwashita","year":"2022","unstructured":"Yukino-Iwashita, M. et al. Short-chain fatty acids in gut-heart axis: Their role in the pathology of heart failure. J Pers Med. 12(11), 1805 (2022).","journal-title":"J Pers Med."},{"issue":"8","key":"46524_CR19","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.3390\/biomedicines11082313","volume":"11","author":"SK Masenga","year":"2023","unstructured":"Masenga, S. K., Povia, J. P., Lwiindi, P. C. & Kirabo, A. Recent advances in microbiota-associated metabolites in heart failure. Biomedicines 11(8), 2313 (2023).","journal-title":"Biomedicines"},{"key":"46524_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2023.1152349","volume":"13","author":"QL Zhang","year":"2023","unstructured":"Zhang, Q. L. et al. Relationship between disorders of the intestinal microbiota and heart failure in infants with congenital heart disease. Front. Cell. Infect. Microbiol. 13, 1152349 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"46524_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s40168-022-01437-2","volume":"10","author":"Y Huang","year":"2022","unstructured":"Huang, Y. et al. Mapping the early life gut microbiome in neonates with critical congenital heart disease: Multiomics insights and implications for host metabolic and immunological health. Microbiome. 10(1), 245 (2022).","journal-title":"Microbiome."},{"key":"46524_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virol.2023.03.008","volume":"582","author":"X Zheng","year":"2023","unstructured":"Zheng, X., Wang, R. & Yin, C. An untargeted metabolomics investigation in liver of flaviviruses-infected mice. Virology 582, 12\u201322 (2023).","journal-title":"Virology"},{"issue":"482","key":"46524_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.136616","volume":"15","author":"D Wu","year":"2025","unstructured":"Wu, D. et al. Female zebrafish are more affected than males under polystyrene microplastics exposure. J. Hazard Mater. 15(482), 136616 (2025).","journal-title":"J. Hazard Mater."},{"issue":"267","key":"46524_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecoenv.2023.115653","volume":"15","author":"H Yu","year":"2023","unstructured":"Yu, H. et al. Improving red pitaya fruit quality by nano-selenium biofortification to enhance phenylpropanoid and betalain biosynthesis. Ecotoxicol. Environ. Saf. 15(267), 115653 (2023).","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"1","key":"46524_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata, H. et al. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 27(1), 29\u201334 (1999).","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"46524_CR26","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1067\/mhj.2002.121265","volume":"143","author":"S L\u00e4er","year":"2002","unstructured":"L\u00e4er, S. et al. Carvedilol therapy in pediatric patients with congestive heart failure: A study investigating clinical and pharmacokinetic parameters. Am. Heart J. 143(5), 916\u2013922 (2002).","journal-title":"Am. Heart J."},{"issue":"8","key":"46524_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.789325","volume":"29","author":"T Hayashi","year":"2021","unstructured":"Hayashi, T. et al. Uncovering the role of gut microbiota in amino acid metabolic disturbances in heart failure through metagenomic analysis. Front. Cardiovasc. Med. 29(8), 789325 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"46524_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2020.1823801","volume":"12","author":"FJ Carrillo-Salinas","year":"2020","unstructured":"Carrillo-Salinas, F. J. et al. Gut dysbiosis induced by cardiac pressure overload enhances adverse cardiac remodeling in a T cell-dependent manner. Gut Microbes. 12(1), 1\u201320 (2020).","journal-title":"Gut Microbes."},{"issue":"5","key":"46524_CR29","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.chom.2015.03.005","volume":"17","author":"CJ Kelly","year":"2015","unstructured":"Kelly, C. J. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 17(5), 662\u2013671 (2015).","journal-title":"Cell Host Microbe."},{"issue":"8","key":"46524_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.691564","volume":"14","author":"A Vijay","year":"2021","unstructured":"Vijay, A. et al. Dietary interventions reduce traditional and novel cardiovascular risk markers by altering the gut microbiome and their metabolites. Front. Cardiovasc. Med. 14(8), 691564 (2021).","journal-title":"Front. Cardiovasc. Med."},{"issue":"5","key":"46524_CR31","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1161\/CIRCULATIONAHA.118.035235","volume":"139","author":"TWH Tang","year":"2019","unstructured":"Tang, T. W. H. et al. Loss of gut microbiota alters immune system composition and cripples postinfarction cardiac repair. Circulation 139(5), 647\u2013659 (2019).","journal-title":"Circulation"},{"issue":"1","key":"46524_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14744\/cpr.2023.30075","volume":"46","author":"L Askin","year":"2024","unstructured":"Askin, L., Polat, E. & Tanriverdi, O. Propionic acidemia, cardiomyopathies, and arrhythmias. J. Clin. Pract. Res. 46(1), 11\u201318 (2024).","journal-title":"J. Clin. Pract. Res."},{"issue":"15","key":"46524_CR33","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1097\/CM9.0000000000000330","volume":"132","author":"X Chen","year":"2019","unstructured":"Chen, X., Li, H. Y., Hu, X. M., Zhang, Y. & Zhang, S. Y. Current understanding of gut microbiota alterations and related therapeutic intervention strategies in heart failure. Chin. Med. J. (Engl). 132(15), 1843\u20131855 (2019).","journal-title":"Chin. Med. J. (Engl)."},{"issue":"2","key":"46524_CR34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/biomedicines11020442","volume":"11","author":"W Yu","year":"2023","unstructured":"Yu, W., Jiang, Y., Xu, H. & Zhou, Y. The Interaction of Gut Microbiota and Heart Failure with Preserved Ejection Fraction: From Mechanism to Potential Therapies. Biomedicines. 11(2), 442 (2023).","journal-title":"Biomedicines."},{"issue":"8","key":"46524_CR35","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jchf.2018.05.018","volume":"6","author":"N Savji","year":"2018","unstructured":"Savji, N. et al. The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF. JACC Heart Fail. 6(8), 701\u2013709 (2018).","journal-title":"JACC Heart Fail."},{"issue":"1","key":"46524_CR36","doi-asserted-by":"publisher","first-page":"1936379","DOI":"10.1080\/19490976.2021.1936379","volume":"13","author":"J Xu","year":"2021","unstructured":"Xu, J. & Yang, Y. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases. Gut Microbes 13(1), 1936379 (2021).","journal-title":"Gut Microbes"},{"issue":"1","key":"46524_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/jcp.25.1.17","volume":"25","author":"DP Rose","year":"1972","unstructured":"Rose, D. P. Aspects of tryptophan metabolism in health and disease: A review. J. Clin. Pathol. 25(1), 17\u201325 (1972).","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"46524_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1744-9987.2010.00882.x","volume":"15","author":"T Niwa","year":"2011","unstructured":"Niwa, T. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: Experimental and clinical effects of oral sorbent AST-120. Ther. Apher Dial. 15(2), 120\u2013124 (2011).","journal-title":"Ther. Apher Dial."},{"issue":"4","key":"46524_CR39","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1574-6976.2009.00204.x","volume":"34","author":"JH Lee","year":"2010","unstructured":"Lee, J. H. & Lee, J. Indole as an intercellular signal in microbial communities. FEMS Microbiol. Rev. 34(4), 426\u2013444 (2010).","journal-title":"FEMS Microbiol. Rev."},{"issue":"7","key":"46524_CR40","doi-asserted-by":"publisher","first-page":"C685","DOI":"10.1152\/ajpcell.00236.2012","volume":"304","author":"H Shimizu","year":"2013","unstructured":"Shimizu, H., Saito, S., Higashiyama, Y., Nishijima, F. & Niwa, T. CREB, NF-\u03baB, and NADPH oxidase coordinately upregulate indoxyl sulfate-induced angiotensinogen expression in proximal tubular cells. Am. J. Physiol. Cell Physiol. 304(7), C685\u2013C692 (2013).","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"46524_CR41","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","volume":"5","author":"L Dou","year":"2007","unstructured":"Dou, L. et al. The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells. J. Thromb Haemost. 5(6), 1302\u20131308 (2007).","journal-title":"J. Thromb Haemost."},{"issue":"7","key":"46524_CR42","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1161\/CIRCRESAHA.121.320548","volume":"130","author":"K Ma","year":"2022","unstructured":"Ma, K. et al. Therapeutic and prognostic significance of arachidonic acid in heart failure. Circ Res. 130(7), 1056\u20131071 (2022).","journal-title":"Circ Res."},{"issue":"3","key":"46524_CR43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1517\/17425255.2014.872240","volume":"10","author":"N Aspromonte","year":"2014","unstructured":"Aspromonte, N. et al. Modulation of cardiac cytochrome P450 in patients with heart failure. Expert Opin. Drug. Metab. Toxicol. 10(3), 327\u2013339 (2014).","journal-title":"Expert Opin. Drug. Metab. Toxicol."},{"issue":"6","key":"46524_CR44","doi-asserted-by":"publisher","first-page":"36949","DOI":"10.1038\/srep36949","volume":"11","author":"C Li","year":"2016","unstructured":"Li, C. et al. Qishen granules inhibit myocardial inflammation injury through regulating arachidonic acid metabolism. Sci. Rep. 11(6), 36949 (2016).","journal-title":"Sci. Rep."},{"issue":"11","key":"46524_CR45","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.3390\/ijms19113285","volume":"19","author":"T Sonnweber","year":"2018","unstructured":"Sonnweber, T., Pizzini, A., Nairz, M., Weiss, G. & Tancevski, I. Arachidonic acid metabolites in cardiovascular and metabolic diseases. Int. J. Mol. Sci. 19(11), 3285 (2018).","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"46524_CR46","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12964-019-0445-0","volume":"17","author":"S Maekawa","year":"2019","unstructured":"Maekawa, S. et al. Linoleic acid improves assembly of the CII subunit and CIII2\/CIV complex of the mitochondrial oxidative phosphorylation system in heart failure. Cell Commun. Signal. 17(1), 128 (2019).","journal-title":"Cell Commun. Signal."},{"key":"46524_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2021.106608","volume":"158","author":"S Wang","year":"2022","unstructured":"Wang, S. et al. Shengmai Yin formula exerts cardioprotective effects on rats with chronic heart failure via regulating linoleic acid metabolism. Prostaglandins Other Lipid Mediat. 158, 106608 (2022).","journal-title":"Prostaglandins Other Lipid Mediat."},{"issue":"3","key":"46524_CR48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.108.114264","volume":"52","author":"AJ Chicco","year":"2008","unstructured":"Chicco, A. J. et al. Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets. Hypertension 52(3), 549\u2013555 (2008).","journal-title":"Hypertension"},{"issue":"4","key":"46524_CR49","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1139\/cjpp-2018-0398","volume":"97","author":"SK Cheema","year":"2019","unstructured":"Cheema, S. K., Tappia, P. S. & Dhalla, N. S. Modification of gene expression in rat cardiomyocytes by linoleic and docosahexaenoic acids 1. Can. J. Physiol. Pharmacol. 97(4), 320\u2013327 (2019).","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"7","key":"46524_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167271","volume":"1870","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. Aged microbiota exacerbates cardiac failure by PPAR\u03b1\/PGC1\u03b1 pathway. Biochimica et Biophys. Acta (BBA) 1870(7), 167271 (2024).","journal-title":"Biochimica et Biophys. Acta (BBA)"},{"issue":"1","key":"46524_CR51","doi-asserted-by":"publisher","first-page":"44","DOI":"10.7150\/ijms.102763","volume":"22","author":"Z Guo","year":"2025","unstructured":"Guo, Z. et al. Cardiomyopeptide- regulated PPAR\u03b3 expression plays a critical role in maintaining mitochondrial integrity and preventing cardiac ischemia\/reperfusion injury. Int. J. Med. Sci. 22(1), 44\u201352 (2025).","journal-title":"Int. J. Med. Sci."},{"issue":"1","key":"46524_CR52","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3390\/metabo14010072","volume":"14","author":"G De Bernardo","year":"2024","unstructured":"De Bernardo, G. et al. Analysis of the fecal metabolomic profile in breast vs. different formula milk feeding in late preterm infants. Metabolites 14(1), 72 (2024).","journal-title":"Metabolites"},{"issue":"1","key":"46524_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13010166","volume":"13","author":"M Wang","year":"2025","unstructured":"Wang, M., Valizadegan, N., Fields, C. J. & Donovan, S. M. Fecal microbiome and metabolomic profiles of mixed-fed infants are more similar to formula-fed than breastfed infants. Microorganisms 13(1), 166 (2025).","journal-title":"Microorganisms"},{"key":"46524_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.660456","volume":"8","author":"N Sillner","year":"2021","unstructured":"Sillner, N. et al. Longitudinal profiles of dietary and microbial metabolites in formula- and breastfed infants. Front. Mol. Biosci. 8, 660456 (2021).","journal-title":"Front. Mol. Biosci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46524-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46524-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46524-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:03:48Z","timestamp":1779149028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46524-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46524"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46524-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Fujian Children\u2019s Hospital (2022ETKLR10079) and strictly adhered to the tenets of the Declaration of Helsinki. The parents or guardians of the patients gave written informed consent for their respective minors to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"15381"}}